Trial intelligence / Profile preview

Baclofen for relapse prevention after GHB detoxification

NL-OMON39314Active, not recruiting

Sponsor
Mental Health Care
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of baclofen in gamma-hydroxybutyrate addiction (GHB) (2 arms), sponsored by Mental Health Care. Primary endpoint: Substance use levels. Started Jul 2014; status: active, not recruiting.

02

Drugs

baclofen
03

Conditions

gamma-hydroxybutyrate addiction (GHB)

Beyond the preview

Go deeper on NL-OMON39314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON39314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call